The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy
NCT: NCT06097195 · RECRUITING
Brief Summary
Neuronostics plan a prospective multisite trial to determine the clinical utility of BioEP in the context of diagnostic decision making. Neuronostics will use findings from the trial to improve user experience of the Neuronostics platform (the tool which clinicians use to obtain a BioEP score from EEG and the aligned report). The data coming from the trial will also enable Neuronostics to iterate the BioEP algorithms and so improve future performance.
Frequently Asked Questions
What is The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy?
The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy is a clinical trial registered under NCT06097195. Current status: RECRUITING.
What is the status of NCT06097195?
The current status of NCT06097195 (The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy) is: RECRUITING.
When did The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy start?
The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy started on 2024-05-21.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.